Nalaganje...

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia

The current treatment for pediatric acute lymphoblastic leukemia (ALL) is highly successful with high cure rate. However, the treatment of adult ALL remains a challenge, particularly for refractory and/or relapsed (R/R) ALL. The advent of new targeted agents, blinatumomab, inotuzumab ozogamycin, and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Hematol Oncol
Main Authors: Zhao, Juanjuan, Song, Yongping, Liu, Delong
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376657/
https://ncbi.nlm.nih.gov/pubmed/30764841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0705-x
Oznake: Označite
Brez oznak, prvi označite!